ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals | Fierce Pharma
Sotagliflozin for the Treatment of Heart Failure, US
Sotagliflozin – Wikipedia
A Type 1 Diabetes Pill? Newest Sotagliflozin Trial Results
Lexicon Pharmaceuticals, Inc. Trademarks & Logos
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INPEFA safely and effect
SGLT2 Inhibitors Added to ESC Guidelines for Treatment of Chronic HFrEF
Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor - Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands, 2015
Theracos, Cuban's Cost Plus team up to launch new SGLT2 drug
PDF) Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor
Sameh Almaqbali en LinkedIn: Sotagliflozin, a novel agent that inhibits sodium-glucose cotransporter…
Pragati Arora on LinkedIn: #diabetescare #diabetesmanagement #healthcare #marketing #brandmanagement
Now Approved | INPEFA™ (sotagliflozin)
Inpefa: Package Insert / Prescribing Information - Drugs.com
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs | MedPage Today
Bayer's Kerendia to compete against SGLT-2 inhibitors < Pharma < Article - KBR
Lexicon Announces FDA Approval of INPEFA (Sotagliflozin) for Treatment of Heart Failure | DAIC
FDA starts review of Sanofi's oral type 1 diabetes drug - PMLiVE
Sotagliflozin for the Treatment of Heart Failure, US
Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor - Pablo Lapuerta, Brian Zambrowicz, Paul Strumph, Arthur Sands, 2015
Dual or single SGLT inhibition: which is more beneficial for type 2 diabetes? Study sheds light
Inpefa: Package Insert / Prescribing Information - Drugs.com
A Type 1 Diabetes Pill? Newest Sotagliflozin Trial Results
Muthu Vaduganathan on Twitter: "Sotagliflozin (INPEFA) receives *broad* @US_FDA approval based on #SOLOISTWHF & #SCORED to reduce CV death, HF hosp, & urgent HF visits in either: HF or T2D, CKD, and
Two Pills for Type 1 Diabetes Under US and European Review
